Tuesday, June 25, 2013

IBC Life Sciences Influenza & Coronavirus Pandemic Preparedness Conference Asia 2013

About The Conference

IBC Asia’s Influenza & Coronavirus Pandemic Preparedness Asia 2013 Conference brings together international and regional experts in one platform to review strategies and best practices to deal with a potential pandemic.
In addition, issues with establishing sustainable public-private partnerships to effectively address the looming threats of novel viruses will be critically examined.

Event Overview

The mortality rate from the MER-CoV virus has now hit 60%, with 30 deaths to date across the Middle East and now spreading to France, Britain and Germany (as at 1 June 2013).
Not only has this virus been in the news, but also the recent occurrence of H7N9, which has had 130 confirmed cases to date (as at 1 June 2013).
Most countries are armed with more experience to deal with such outbreaks than 10 years ago when there was the SARs outbreak. However, issues of rapid development and deployment of vaccines/drugs and efficient disease surveillance and control remain significant.
Hampered by insufficient understanding of the new viruses, efficient and effective contingency planning is in particular important to containing the spread of a new disease.

IBC Asia’s Pandemic Preparedness Asia 2013 Conference brings together international and regional experts in one platform to review strategies and best practices to deal with a potential pandemic.
In addition, issues with establishing sustainable public-private partnerships to effectively address the looming threats of novel viruses will be critically examined.








No comments: